AR and benign prostatic hyperplasia: The overexpression of AR, SRC-1, PSA, and PCNA in BPH-1 cells was significantly inhibited by UMB treatment, indicating that UMB inhibits androgen/AR signaling-dependent cell proliferation (Figure 1).